AIDS Healthcare Foundation…commended Merck…over price cuts on two of its key AIDS drugs in Mexico... Merck cut its price of Stocrin…in Mexico by 40%...and on Isentress…by 30%... [According to] Michael Weinstein, AIDS Healthcare Foundation President…“Though there is still much to be done in the fight for affordable lifesaving AIDS drugs in Mexico and throughout the world…we commend Merck today for instituting these double digit price reductions in response to activists’ pleas for lower prices…”